Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: Results from the retrospective, multicentre, OnCovid registry study

by on 12 de setembre de 2022 with No hi ha comentaris
  • Pinato, D. J., Aguilar-Company, J., Ferrante, D., Hanbury, G., Bower, M., Salazar, R., Tabernero, J., . . . OnCovid study group. (2022). Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: Results from the retrospective, multicentre, OnCovid registry study. The Lancet Oncology, 23(7), 865-875. https://doi.org/10.1016/S1470-2045(22)00273-X

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *